Old HIV drug repurposed to hunt and kill hidden virus
NCT ID NCT06823596
Summary
This study is testing if adding an old HIV drug, efavirenz, to a person's current treatment can kill cells that are still producing small amounts of HIV. It focuses on people whose virus levels are very low but still detectable despite excellent treatment adherence. The goal is to see if this approach can reduce the hidden 'reservoir' of virus and lower detectable virus levels, potentially improving long-term health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maple Leaf Medical Clinic
RECRUITINGToronto, Ontario, M5G 1K2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unity Health Toronto -St. Michael's Hospital
RECRUITINGToronto, Ontario, M5B 1W8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.